Thursday, March 14, 2013
Publication and contact
In vitro and mouse studies identified variants of IL17RA
that could help treat plaque psoriasis. In cell-based assays, soluble,
mutated versions of IL17RA bound IL-17A and decreased IL-17A-induced
secretion of inflammatory cytokines from human fibroblast cells compared with
the soluble, wild-type receptor. In a mouse model for plaque psoriasis,
subcutaneous injection of an IL17RA variant improved skin recovery with
potency comparable to that of dexamethasone, a generic anti-inflammatory
steroid. Next steps include preclinical testing of the compounds in
additional autoimmune indications.
Inc. and AstraZeneca
plc have brodalumab, a humanized mAb against
IL17RA, in Phase III testing to treat psoriasis.
At least two other companies have inhibitors or antibodies targeting IL17RA
in Phase II testing or earlier to treat psoriasis.
Published online March 14, 2013
Patent application filed;
available for licensing
Zaretsky, M. et al.
published online Feb. 21, 2013;
Contact: Amir Aharoni, Ben-Gurion University of the Negev,
Be'er Sheva, Israel
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]